Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABCD2 ScoreACR CriteriaCorrected SodiumFENaHEART ScoreLights CriteriaNEWS2NRS-2002Osmolality GapRCRI (Lee Score)TTKG
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

Lights Criteria

Light's Criteria: Gold standard for differentiating pleural exudates from transudates. ≥ 1 of 3 criteria met = exudate. Sensitivity 98%, Specificity 83%.
Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

Mandatory first step in the evaluation of any new pleural effusion via diagnostic thoracentesis.
Differentiating systemic hydrostatic/oncotic pressure issues (Transudates) from local pleural disease (Exudates).
Screening for malignant pleural effusion (MPE) or complicated parapneumonic effusions.

Transudate vs. Exudate Etiology

TransudatesCHF (86%), Cirrhosis (7%), Nephrotic Syndrome, Peritoneal Dialysis.
ExudatesMalignancy (41%), Infection/Pneumonia (25%), TB (9%), PE, Uremia.

How it Works

Standard Light's Criteria (Serum-Dependent)

Pleural Fluid Protein : Serum Protein ratio > 0.5
Pleural Fluid LDH : Serum LDH ratio > 0.6
Pleural Fluid LDH > 2/3 the Upper Limit of Normal (ULN) Serum LDH

The 2026 'Triple Combination' (Blood-Free)

Validated in >7,000 patients (Porcel et al., 2026). If blood sampling is unavailable, an effusion is classified as an EXUDATE if it meets ANY of these PF-only criteria: 1. PF Protein > 3 g/dL 2. PF LDH > 250 IU/L 3. PF Cholesterol > 55 mg/dL

Interpretation Rule

Light's Criteria: Any 1 positive = Exudate (Sensitivity 98%, Specificity ~71%). Triple Combination: Matches accuracy of Light's and reclassifies ~20% of false-positive transudates.

Clinical Pearls

The Diuretic Challenge

Diuretics in CHF patients can 'concentrate' pleural fluid, causing a transudate to meet exudative criteria (pseudo-exudate).

Albumin & Protein Gradients

Serum-Effusion Protein Gradient: (Serum Protein - Pleural Protein) > 3.1 g/dL = Transudate Serum-Effusion Albumin Gradient (SEAG): (Serum Albumin - Pleural Albumin) > 1.2 g/dL = Transudate

Malignancy Pearls (CEA Interaction)

An LDH ratio > 0.6 is independently associated with false-negative CEA results in malignant effusions (Yang et al., 2025).
CEA > 10 ng/mL is highly suggestive of MPE, but 40% of MPEs are CEA-negative.
Internet-active patients often prefer allografts in surgical contexts—similarly, in medicine, patients may request 'blood-free' testing (Triple Rule) to avoid repeat venipuncture.

The Evidence

The 2026 Validation (Triple Rule)

Revisiting Light's criteria: a validated blood-free triple combination matches diagnostic accuracy in over 7000 patients.

Porcel JM et al. • ERJ Open Research. 2026;Large-scale study (n=7280) proving that a PF-only combination of protein, LDH, and cholesterol matches Light's accuracy while improving specificity for transudates.

View Source

CEA & Light's Interaction

Effects of Light’s criteria on the diagnostic accuracy of pleural fluid carcinoembryonic antigen concentrations for malignant pleural effusion.

Yang DN et al. • Scientific Reports. 2025;Analyzed the positive correlation between CEA and LDH/Protein levels; found that LDH ratio >0.6 predicts false-negative CEA in MPE.

View Source

Historical Standard

Pleural effusions: the diagnostic separation of transudates and exudates.

Light RW et al. • Annals of Internal Medicine. 1972;The seminal paper that established the protein and LDH ratios as the clinical standard for the last 50+ years.

View Source

Origins & History

Dr. Richard Light's Legacy

Before 1972, the differentiation of effusions was inconsistent, often relying solely on protein levels (>3.0 g/dL). Dr. Richard Light introduced the multi-parameter approach to capture the enzymatic activity (LDH) of inflammatory processes.

Evolution of the Rule

01
1972: Light's Criteria published; revolutionizes diagnostic thoracentesis.
02
1990s: Recognition of the 'Diuretic Effect' leads to the adoption of Albumin/Protein gradients.
03
2010s: Pleural cholesterol gains traction as a standalone high-specificity marker.
04
2026: The ERS validates the Blood-Free Triple Combination, allowing for PF-only assessment without loss of sensitivity.

Last Comprehensive Review: 2026

Recent Journal Updates

JAMAJul 21, 2026
Audio Highlights June 26, 2026

Clinical Context

We think this might be relevant to the clinical guidance for Light's Criteria.

WHO NewsJul 20, 2026
Road deaths fall by 21% globally but stronger action is needed to save lives

Clinical Context

We think this might be relevant to the clinical guidance for Light's Criteria.

British J HaematologyJul 20, 2026
Real‐world outcomes of triplet therapy with gilteritinib, azacitidine and venetoclax in FMS‐like tyrosine kinase 3 (FLT3)‐mutated relapsed/refractory acute myeloid leukaemia: A UK single‐centre experience

Clinical Context

We think this has broad domain relevance to Light's Criteria.